Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC-OVPAC 1/2a
NCT07273396Phase 2Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2026
- Primary completion
- Apr 2030
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Seoul National University Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
paclitaxel
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT07273396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07273396.